WallStSmart
CAPR

Capricor Therapeutics Inc

NASDAQ: CAPR · HEALTHCARE · BIOTECHNOLOGY

$33.58
+3.45% today

Updated 2026-04-30

Market cap
$2.04B
P/E ratio
P/S ratio
124.43x
EPS (TTM)
$-2.26
Dividend yield
52W range
$4 – $40
Volume
1.3M

Capricor Therapeutics Inc (CAPR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-26.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-287.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.1%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+4.6%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-25$-0.62-20.9%$28.87$29.95+3.7%
2025-11-10$-0.54+0.0%$5.93$6.20+4.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.51$-0.62-20.9%
2025-09-30$-0.54$-0.54+0.0%
2025-06-30$-0.48$-0.57-18.7%
2025-03-31$-0.32$-0.53-66.7%
2024-12-31$-0.09$-0.16-70.2%$11.13M-7.9%
2024-09-30$-0.36$-0.38-5.6%$2.26M-63.4%
2024-06-30$-0.36$-0.35+2.8%$3.97M+1.4%
2024-03-31$-0.11$-0.31-181.8%$4.91M+64.3%
2023-12-31$-0.09$-0.02+77.8%$12.09M
2023-09-30$-0.29$-0.25+13.8%$6.19M
2023-06-30$-0.35$-0.29+17.1%$3.92M
2023-03-31$-0.32$-0.31+3.1%$2.99M

Frequently asked questions

Has Capricor Therapeutics Inc beaten earnings estimates?
Capricor Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -26.6% over the last 4 quarters.
How does CAPR stock react to earnings?
CAPR stock has moved an average of +4.1% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.